You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 6, 2024

Claims for Patent: 11,311,541

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,311,541

Title:	Treatment of GVHD
Abstract:	The invention relates to treatment of graft versus host disease (GVHD) using compounds that inhibit ROCK2. In preferred aspects, the present invention provides methods for the treatment of GVHD, including chronic GVHD (cGVHD) using compounds having the formulae 1-XXV, as set forth herein.
Inventor(s):	Zanin-Zhorov; Alexandra (Staten Island, NY), Blazar; Bruce Robert (Golden Valley, MN), Flynn; Ryan (Minneapolis, MN)
Assignee:	KADMON CORPORATION, LLC (New York, NY) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, MN)
Application Number:	15/303,420
Patent Claims:	1. A method of treating sclerodermatous chronic graft versus host disease in a subject in need thereof, which comprises administering to the subject an effective amount of a compound of Formula: ##STR00270## or pharmaceutically acceptable salt thereof. 2. The method of claim 1, wherein the compound is administered to the subject with a second agent.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.